Genomic and proteomic biomarker landscape in clinical trials

The use of molecular biomarkers to support disease diagnosis, monitor its progression, and guide drug treatment has gained traction in the last decades. While only a dozen biomarkers have been approved for their exploitation in the clinic by the FDA, many more are evaluated in the context of transla...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñero, Janet, Rodriguez Fraga, Pablo S., Valls-Margarit, Jordi, Ronzano, Francesco, Accuosto, Pablo, Lambea Jane, Ricard, Sanz, Ferran, Furlong, Laura I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036891/
https://www.ncbi.nlm.nih.gov/pubmed/36968019
http://dx.doi.org/10.1016/j.csbj.2023.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036891/
https://www.ncbi.nlm.nih.gov/pubmed/36968019
http://dx.doi.org/10.1016/j.csbj.2023.03.014

Ejemplares similares